“Prediabetes doesn’t matter unless it turns into diabetes.”
Prediabetes matters because it signals a higher chance of developing diabetes and often comes with heart risk factors.
Prediabetes is an early warning and a good chance to act, not a sentence. Many people who make steady changes in activity, food and weight never develop diabetes.
Confirm the result with your clinician and ask about a structured diabetes prevention program near you.
Safety note: A1C can be misleading with anemia, altered red-cell turnover, some hemoglobin variants, kidney disease and pregnancy. Do not start medication or extreme dieting from one result without confirming the diagnosis and clinical context.
Talk to a healthcare professional if: you get a prediabetes result, especially if values are rising or you have had gestational diabetes, carry extra weight, have a strong family history, heart disease or take medicines that raise blood sugar.
Strong confidence because prediabetes marks a higher risk of future diabetes, and randomized trials show that lifestyle change and metformin can delay or prevent it in high-risk adults. Current American Diabetes Association guidance recommends at least yearly checks and prevention programs.
Prediabetes matters because it signals a higher chance of developing diabetes and often comes with heart risk factors. Acting at this stage can delay or prevent diabetes: in a large trial, a lifestyle program cut new cases by 58% over about three years.
Prediabetes is a risk category, not a guarantee that diabetes will follow. A1C, fasting glucose and glucose-tolerance tests pick out overlapping but different groups, and A1C can be misleading with anemia, some hemoglobin variants, kidney disease and pregnancy.
- American Diabetes Association Professional Practice Committee. 3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes-2026. Diabetes Care. 2026;49(Suppl 1):S50-S60. DOI: 10.2337/dc26-S003
- Diabetes Prevention Program Research Group. Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. New England Journal of Medicine. 2002;346(6):393-403. DOI: 10.1056/NEJMoa012512. PMID: 11832527. PMCID: PMC1370926
- Knowler WC, Pan Q, Shu S, et al.; Diabetes Prevention Program Research Group. Analysis of Long-term Follow-up of a Randomized Clinical Trial With Departures From Assigned Treatments: Estimation of Metformin Effects on Diabetes and Its Complications in the Diabetes Prevention Program Outcomes Study. Diabetes Care. 2025;48(10):1668-1675. DOI: 10.2337/dci25-0032. PMID: 40857175. PMCID: PMC12451852